| First Published on Clinicaltrials.gov: |
11/22/2009 |
| Status: |
Currently Recruiting |
| ClinicalTrials.gov ID: |
NCT00563537 |
| Sponsor: |
University Hospital, Tours |
| Purpose: |
This study was designed to explore the feasibility of molecular imaging modality by Positron Emission Tomography using 18F-X as an in vivo marker of activated microglia for the assessment of neuroinflammation in amyotrophic lateral sclerosis. |
| Phase: |
II |
| Treatment Type: |
Collection of Images |
| Trial Type: |
Open label |
| Estimated Enrollment: |
30 |
| Eligibility: |
40 years to 70 years old. Both Genders. Accepting healthy volunteers. |
| Details: |
One arm study: experimental 18F-X PET Scan imaging |
| Collaborator(s): |
|
| Location(s): |
|
| Primary Investigator: |
Philippe CORCIA, MD |
| Contact: |
|
| Trial Protocol as Published on Clinicaltrials.gov: |
|
| ALS Forum: |
|